 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Mongolian Anti Tuberculosis Coalition |
| Street 1: | Gyals medical center, 4th khoroo, Bayanzurkh district, Ulaanbaatar, Mongolia |
| Street 2: | |
| City: | Ulaanbaatar |
| Province: | |
| Post Code: | 11000 |
| Country: | Mongolia |
| Phone: | +97699099471 |
| Organization Email: | info@mtbc.mn |
| Web Site: | http://www.endtb.mn/ |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 8044414 |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Other Non-Governmental Organization (NGO) |
| Organization Description: | |
| Our main focus area is research and development. Our goal is ensuring community participation in ending tuberculosis in Mongolia and supporting the national system to provide quality and accessible tuberculosis care services using evidence-based and human rights-protected methods. | |
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Advocacy Civil Society and Community Engagement Engaging political leaders and ensuring inclusive leadership Research and Development Working on Community, Rights and Gender (CRG) |
Other Organization Information | |
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 11 - 25 |
| Number of volunteers who are directly involved with TB: | 26 - 50 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Our team members are not only a team of renowned scientists in Mongolia, but also have experience working in the direction of developing national programs and providing advice to NTP. Our organization is responsible for coordinating STREAM clinical trial in Mongolia, and initiated TB STIGMA Assessment in Mongolia. |
|
Geographical Reach | |
| Which country is your headquarters located in: | Mongolia |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Mongolia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Involved The STREAM (Evaluation of a Standardized Treatment Regimen of Anti-tuberculosis Drugs for Patients with Multidrug-resistant Tuberculosis) clinical trial is the first large-scale, multi-country clinical trial to examine shortened regimens for MDR-TB. Drug-Resistant TB: Involved in The STREAM (Evaluation of a Standardized Treatment Regimen of Anti-tuberculosis Drugs for Patients with Multidrug-resistant Tuberculosis) clinical trial is the first large-scale, multi-country clinical trial to examine shortened regimens for MDR-TB. Laboratory Strengthening: Involved The STREAM (Evaluation of a Standardized Treatment Regimen of Anti-tuberculosis Drugs for Patients with Multidrug-resistant Tuberculosis) clinical trial is the first large-scale, multi-country clinical trial to examine shortened regimens for MDR-TB. New TB Drugs: Involved The STREAM (Evaluation of a Standardized Treatment Regimen of Anti-tuberculosis Drugs for Patients with Multidrug-resistant Tuberculosis) clinical trial is the first large-scale, multi-country clinical trial to examine shortened regimens for MDR-TB. Fundamental Research: Implemented TB Stigma Assessment in Mongolia with NTP, MATA, National Human Rights committee, CCM, Global fund Research: Involved The STREAM (Evaluation of a Standardized Treatment Regimen of Anti-tuberculosis Drugs for Patients with Multidrug-resistant Tuberculosis) clinical trial is the first large-scale, multi-country clinical trial to examine shortened regimens for MDR-TB. Implemented TB Stigma Assessment in Mongolia with NTP, MATA, National Human Rights committee, CCM, Global fund |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | February 6, 2023 |
| Last updated: | February 6, 2023 |